Management of Non-Oncological Pain with Morphine Luis M. Torres OriginalPaper 11 November 2012 Pages: 1 - 5
Continuous Pain Control in Patients with Cancer Louis Brasseur OriginalPaper 11 November 2012 Pages: 6 - 14
Opioids for the Management of Severe Pain in Children and Infants Joëlle F. Desparmet OriginalPaper 11 November 2012 Pages: 15 - 21
Double-Blind Crossover Clinical and Pharmacokinetic Comparison of Oral Morphine Syrup and Sustained Release Morphine Sulfate Capsules in Patients with Cancer-Related Pain Jean-François GilletteChristophe FermeDominique Belpomme OriginalPaper 11 November 2012 Pages: 22 - 27
Randomised Crossover Comparison of the Pharmacokinetic Profiles of Two Sustained Release Morphine Sulfate Formulations in Patients with Cancer-Related Pain Mario De BernardiFrancesca De BernardiPaolo Colombo OriginalPaper 11 November 2012 Pages: 28 - 33
Clinical Evaluation of the Analgesic Effect of Sustained Release Morphine Sulfate Microgranules in Patients with Terminal Cancer Guo-Zhu XuZhi-Ji CaiShu-Jun Liu OriginalPaper 11 November 2012 Pages: 34 - 42
Oral Administration of Sustained Release Morphine Sulfate Granules in Patients with Pain and Dysphagia Associated with Cancer Stéphane DonnadieuMichel HernotLaurence Suard OriginalPaper 11 November 2012 Pages: 43 - 52
The Pharmacokinetic Profiles of Two Variations of a Sustained Release Morphine Sulfate Formulation Intended for Once-Daily Administration Pieter J. M. GuelenTom J. JanssenSabine P. Debregeas OriginalPaper 11 November 2012 Pages: 53 - 58
Sustained Release Morphine Sulfate Capsules in Patients with Pain Related to Gastrointestinal Cancer Erika Budai Short Communication 11 November 2012 Pages: 59 - 61
